237 related articles for article (PubMed ID: 11731625)
1. Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
Cooper A; Yusuf H; Rodewald L; Malik T; Pollard R; Pickering L
Pediatrics; 2001 Dec; 108(6):E98. PubMed ID: 11731625
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B immunisation coverage of infants born to chronic carrier mothers in Victoria.
Oman KM; Carnie J; Ruff T
Aust N Z J Public Health; 1997 Dec; 21(7):731-4. PubMed ID: 9489190
[TBL] [Abstract][Full Text] [Related]
4. Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.
;
Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28847980
[TBL] [Abstract][Full Text] [Related]
5. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
Hurie MB; Saari TN; Davis JP
Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
[TBL] [Abstract][Full Text] [Related]
7. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
8. Public health impact of Infanrix hexa™ (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants' vaccination against hepatitis B in general and pediatric practices - the PRALINE study.
Vié le Sage F; Gaudelus J; Lert F; Dufour V; Texier N; Pouriel M; Schück S; Tehard B; Bréart G
Rev Epidemiol Sante Publique; 2016 Jun; 64(3):185-94. PubMed ID: 27238163
[TBL] [Abstract][Full Text] [Related]
9. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time.
Freed GL; Bordley WC; Clark SJ; Konrad TR
Pediatrics; 1994 May; 93(5):747-51. PubMed ID: 8165072
[TBL] [Abstract][Full Text] [Related]
10. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
[TBL] [Abstract][Full Text] [Related]
11. Use of a new combined vaccine in pediatric practices.
Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
13. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series.
Yusuf HR; Daniels D; Smith P; Coronado V; Rodewald L
JAMA; 2000 Aug 23-30; 284(8):978-83. PubMed ID: 10944643
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of universal hepatitis B immunization practices of Illinois pediatricians.
Kraus DM; Campbell MM; Marcinak JF
Arch Pediatr Adolesc Med; 1994 Sep; 148(9):936-42. PubMed ID: 8075737
[TBL] [Abstract][Full Text] [Related]
15. FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):203-4. PubMed ID: 12653460
[TBL] [Abstract][Full Text] [Related]
16. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
17. Universal hepatitis B immunization.
Kim SC; Sinai LN; Casey R; Pinto-Martin JA
Pediatrics; 1995 May; 95(5):764-6. PubMed ID: 7724320
[TBL] [Abstract][Full Text] [Related]
18. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination.
Anderson S; Harper LM; Dionne-Odom J; Halle-Ekane G; Tita ATN
Int J Gynaecol Obstet; 2018 Apr; 141(1):126-132. PubMed ID: 29315536
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
[TBL] [Abstract][Full Text] [Related]
20. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
